Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Estimating the burden of α-thalassaemia in Thailand using a comprehensive prevalence database for Southeast Asia.

Hockham C, Ekwattanakit S, Bhatt S, Penman BS, Gupta S, Viprakasit V, Piel FB.

Elife. 2019 May 23;8. pii: e40580. doi: 10.7554/eLife.40580.

2.

HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.

Nnodu O, Isa H, Nwegbu M, Ohiaeri C, Adegoke S, Chianumba R, Ugwu N, Brown B, Olaniyi J, Okocha E, Lawson J, Hassan AA, Diaku-Akinwumi I, Madu A, Ezenwosu O, Tanko Y, Kangiwa U, Girei A, Israel-Aina Y, Ladu A, Egbuzu P, Abjah U, Okolo A, Akbulut-Jeradi N, Fernandez M, Piel FB, Adekile A.

Blood Cells Mol Dis. 2019 Feb 8. pii: S1079-9796(19)30019-1. doi: 10.1016/j.bcmd.2019.01.007. [Epub ahead of print]

3.

Access to emergency departments for acute events and identification of sickle cell disease in refugees.

De Franceschi L, Lux C, Piel FB, Gianesin B, Bonetti F, Casale M, Graziadei G, Lisi R, Pinto V, Putti MC, Rigano P, Rosso R, Russo G, Spadola V, Pulvirenti C, Rizzi M, Mazzi F, Ruffo G, Forni GL.

Blood. 2019 May 9;133(19):2100-2103. doi: 10.1182/blood-2018-09-876508. Epub 2019 Feb 11. No abstract available.

PMID:
30745303
4.

The spatial epidemiology of sickle-cell anaemia in India.

Hockham C, Bhatt S, Colah R, Mukherjee MB, Penman BS, Gupta S, Piel FB.

Sci Rep. 2018 Dec 6;8(1):17685. doi: 10.1038/s41598-018-36077-w.

5.
6.

Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.

Lobitz S, Telfer P, Cela E, Allaf B, Angastiniotis M, Backman Johansson C, Badens C, Bento C, Bouva MJ, Canatan D, Charlton M, Coppinger C, Daniel Y, de Montalembert M, Ducoroy P, Dulin E, Fingerhut R, Frömmel C, García-Morin M, Gulbis B, Holtkamp U, Inusa B, James J, Kleanthous M, Klein J, Kunz JB, Langabeer L, Lapouméroulie C, Marcao A, Marín Soria JL, McMahon C, Ohene-Frempong K, Périni JM, Piel FB, Russo G, Sainati L, Schmugge M, Streetly A, Tshilolo L, Turner C, Venturelli D, Vilarinho L, Yahyaoui R, Elion J, Colombatti R; with the endorsement of EuroBloodNet, the European Reference Network in Rare Haematological Diseases.

Br J Haematol. 2018 Nov;183(4):648-660. doi: 10.1111/bjh.15600. Epub 2018 Oct 18.

PMID:
30334577
7.

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.

GBD 2016 Healthcare Access and Quality Collaborators.

Lancet. 2018 Jun 2;391(10136):2236-2271. doi: 10.1016/S0140-6736(18)30994-2. Epub 2018 Jun 1.

8.

The challenge of opt-outs from NHS data: a small-area perspective.

Piel FB, Parkes BL, Daby H, Hansell AL, Elliott P.

J Public Health (Oxf). 2018 Dec 1;40(4):e594-e600. doi: 10.1093/pubmed/fdy059. No abstract available.

9.

Sickle cell disease.

Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP.

Nat Rev Dis Primers. 2018 Mar 15;4:18010. doi: 10.1038/nrdp.2018.10. Review.

10.

Subphenotypes of sickle cell disease in Africa.

Piel FB, Williams TN.

Blood. 2017 Nov 16;130(20):2157-2158. doi: 10.1182/blood-2017-10-808550. No abstract available.

11.

Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.

Rigano P, De Franceschi L, Sainati L, Piga A, Piel FB, Cappellini MD, Fidone C, Masera N, Palazzi G, Gianesin B, Forni GL; Italian Multicenter Study of Hydroxyurea in Sickle Cell Anemia Investigators.

Blood Cells Mol Dis. 2018 Mar;69:82-89. doi: 10.1016/j.bcmd.2017.08.017. Epub 2017 Oct 9.

13.

Sickle Cell Disease.

Piel FB, Steinberg MH, Rees DC.

N Engl J Med. 2017 Jul 20;377(3):305. doi: 10.1056/NEJMc1706325. No abstract available.

14.

Sickle Cell Disease.

Piel FB, Steinberg MH, Rees DC.

N Engl J Med. 2017 Apr 20;376(16):1561-1573. doi: 10.1056/NEJMra1510865. Review. No abstract available.

15.

Associations between environmental factors and hospital admissions for sickle cell disease.

Piel FB, Tewari S, Brousse V, Analitis A, Font A, Menzel S, Chakravorty S, Thein SL, Inusa B, Telfer P, de Montalembert M, Fuller GW, Katsouyanni K, Rees DC.

Haematologica. 2017 Apr;102(4):666-675. doi: 10.3324/haematol.2016.154245. Epub 2016 Dec 1.

18.

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators.

Lancet. 2016 Oct 8;388(10053):1545-1602. doi: 10.1016/S0140-6736(16)31678-6. Erratum in: Lancet. 2017 Jan 7;389(10064):e1.

19.
20.

Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015.

GBD 2015 SDG Collaborators.

Lancet. 2016 Oct 8;388(10053):1813-1850. doi: 10.1016/S0140-6736(16)31467-2. Epub 2016 Sep 21. Erratum in: Lancet. 2017 Jan 7;389(10064):e1.

Supplemental Content

Loading ...
Support Center